| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/09/1998 | EP0862554A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 09/09/1998 | EP0862553A1 Cbi analogs of cc-1065 and the duocarmycins |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862445A1 Methods and compositions for viral enhancement of cell killing |
| 09/09/1998 | EP0862443A1 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862432A1 Two-photon upconverting dyes and applications |
| 09/09/1998 | EP0746544B1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192740A Novel camptothecin analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192694A Vector for diagnosis and treatment of solid tumors including melanoma |
| 09/09/1998 | CN1192693A Therapeutic agent and autoimmune diseases |
| 09/09/1998 | CN1192680A Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 09/09/1998 | CN1192678A Biological agent compositions |
| 09/09/1998 | CN1192365A Traditional Chinese medicine for treating mastosis |
| 09/09/1998 | CN1192364A Traditional Chinese medicine for treating gynecological tumour |
| 09/09/1998 | CN1039708C Method for prepn. of diiodo-compound |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804582 Administering immunogenic organic amine salt of n,n'-diacetylcystine |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 09/08/1998 | US5804183 Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
| 09/08/1998 | US5804157 Somatostatin with unmodified carboxy terminal amino acid;diagnostic or theraputic use for targeting biological site; |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038319A1 Component of bromelain |
| 09/03/1998 | WO1998038310A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | WO1998038307A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | WO1998038291A1 Component of bromelain |
| 09/03/1998 | WO1998038207A1 Compositions for treating or preventing prostatic cancer |
| 09/03/1998 | WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038178A1 Tripeptide and tetrapeptide pharmaceutical compounds |
| 09/03/1998 | WO1998038164A1 Selective epoxidation process for preparing pharmaceutical compounds |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998038158A1 Process for preparing pharmaceutical compounds |
| 09/03/1998 | WO1998037905A1 Arrestable therapeutic viral agent |
| 09/03/1998 | WO1998037900A1 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037874A1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
| 09/03/1998 | WO1998037765A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| 09/03/1998 | WO1998028317A3 Synthesis of nucleosides and polynucleotides |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | DE19716892C1 Vector for expressing immunoglobulin-cytokine fusion protein |
| 09/03/1998 | CA2283107A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | CA2282836A1 Compositions for treating or preventing prostatic cancer |
| 09/03/1998 | CA2282736A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282264A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | CA2281108A1 Process for preparing pharmaceutical compounds |
| 09/03/1998 | CA2281107A1 Tripeptide and tetrapeptide pharmaceutical compounds |
| 09/03/1998 | CA2281104A1 Selective epoxidation process for preparing pharmaceutical compounds |
| 09/03/1998 | CA2280690A1 Arrestable therapeutic viral agent |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861839A1 Selective epoxidation process for preparing cryptophycin compounds and intermediates |
| 09/02/1998 | EP0861838A2 Process and intermediates for preparing cryptophycin compounds |
| 09/02/1998 | EP0861267A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 09/02/1998 | EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/02/1998 | EP0861253A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 09/02/1998 | EP0861084A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
| 09/02/1998 | EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same |
| 09/02/1998 | EP0732921A4 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/02/1998 | EP0691964B1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation |
| 09/02/1998 | EP0674716B1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | EP0482213B1 Antineoplastic agent |
| 09/02/1998 | EP0413706B1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |
| 09/02/1998 | CN1192220A Novel antiproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192152A Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 09/02/1998 | CN1192149A Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 09/02/1998 | CN1192148A Use of phenol substituted diphosphonates as antineoplastic agents |
| 09/02/1998 | CN1192142A Use of 1H-1,2,4-triazole derivatives for inhibiting the growth of cancers |
| 09/02/1998 | CN1192141A Methods for inhibiting melanoma |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |
| 09/02/1998 | CN1191727A Medicine composite for digestive tract tumor |
| 09/02/1998 | CN1191726A Medicine composite for curing digestive tract tumor and its preparation |
| 09/01/1998 | US5801253 Retinoic acid X-receptor ligands |
| 09/01/1998 | US5801229 Radiation sensitizers; antitumor agents |
| 09/01/1998 | US5801191 Taxoids |
| 09/01/1998 | US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones |
| 09/01/1998 | US5801175 Antitumor/anticarcinogenic agents |
| 09/01/1998 | US5801167 Camptothecin derivatives and process for their preparation |
| 09/01/1998 | US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide |
| 09/01/1998 | US5801156 Macular degeneration |
| 09/01/1998 | US5801152 Antracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 09/01/1998 | US5801145 Method for selectively purging CD77+ cells from bone marrow |
| 09/01/1998 | US5801142 Human mts-1 protein |
| 09/01/1998 | US5801014 Growth differentiation factor-5 |
| 09/01/1998 | US5801012 Methods and compositions for generating angiostatin |